Testing stronger eye drops for fungal eye infections
Treatments studied
Part of Eyes & vision, Infections clinical trials.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a fungal eye infection confirmed by lab test (smear or culture).
- Your vision in the infected eye is between 20/40 and 20/400.
- You are 18 years or older.
- You are willing to follow up at the hospital.
- You are not already taking cyclosporine eye drops.
- You do not have severe eye damage like a hole in the cornea or need a cornea transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational new eye drop called IVIEW-1201 for treating fungal keratitis, a fungal infection of the cornea. It aims to see if it is safe and effective compared to standard treatment, which could help clear the infection and protect your vision.
This study tests a new light-based treatment for a fungal eye infection called Fusarium keratitis. It aims to see if this therapy can help improve vision and clear the infection.
This trial tests a new eye gel that contains cyclosporine (a medicine that lowers inflammation) to see if it helps with dry eye symptoms. If you have long-lasting dry eye, this study might offer a new treatment option.
This study is testing a steroid eye drop (fluorometholone) as an add-on to standard antibiotic treatment for bacterial corneal ulcers. The goal is to see if adding the steroid helps reduce inflammation and improves healing compared to antibiotics alone.
This study tests a new eye drop (T1695) against cyclosporine for children with moderate to severe vernal keratoconjunctivitis, a type of eye allergy. It aims to see which treatment works better and is safer for reducing symptoms.
This study tests a gel form of cyclosporine for people with moderate to severe dry eye that hasn't improved with other treatments. The gel is applied to the eye to help reduce inflammation and increase tear production.
Hear when a new Corneal Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.